PHIDELITY · Physiological Role of Nonsense-Mediated Decay in Herpes Simplex Virus Infection and Pathogenicity
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2022-10-01 → 2025-12-31
- Финансиране от ЕС
- 203 464 €
- Участници
- 1
- Схема
- HORIZON-TMA-MSCA-PF-EF
Линиите свързват координатора с партньорите.
Накратко на български
Естественият механизъм за контрол на качеството в човешките клетки се изследва в контекста на инфекции с херпес вируси. Разбирането на тези защитни процеси е важно за разработването на по-ефективни антивирусни стратегии за лечение.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Physiological Role of Nonsense-Mediated Decay in Herpes Simplex Virus Infection and Pathogenicity
Herpesviruses form an ancient and widespread family of DNA viruses that have coevolved with humans for millions of years. Nine different herpesviruses infect humans and establish lifelong infections that persist silently in the body, allowing them to evade elimination by the immune system. Nevertheless, frequent reactivations enable viruses to spread within the body and between individuals. Well-known members of this family include herpes simplex viruses, varicella zoster virus, human cytomegalovirus, and Epstein–Barr virus. Human herpesviruses are extremely common: depending on the virus, between 20% and 90% of the global adult population is infected. As a result, most people carry several herpesviruses throughout their lifetime. While infections are often mild or asymptomatic, a significant health burden arises from severe complications in vulnerable individuals. These include eye infections that can lead to blindness, life-threatening brain inflammation, and increasing evidence links herpesvirus infections to age-related conditions such as dementia and cardiovascular disease. Given their high prevalence and the limited availability and effectiveness of current vaccines and antiviral treatments, herpesviruses continue to pose a substantial challenge to public health worldwide. A major obstacle to improving prevention, diagnosis, and treatment is our incomplete understanding of how human cells naturally defend themselves against viral infection. In particular, the interactions between viruses and host cell defence mechanisms remain poorly understood. Addressing this knowledge gap is essential for the development of innovative and more effective antiviral strategies. Therefore, this project aimed to identify the role of a natural cellular quality-control mechanism, known as nonsense-mediated RNA decay (NMD), in restricting herpesvirus infection. NMD normally protects cells by identifying and degrading faulty RNA molecules, thereby ensuring proper gene expression. However, its role in controlling viral infections has remained largely unexplored. Using herpes simplex virus type 1 (HSV-1) as a prototypical model system, the project investigated how this cellular pathway influences viral replication and infection outcome. The project demonstrated that NMD plays a previously unrecognised role in limiting herpesvirus infection. By showing that this host defence mechanism actively restricts viral replication across different experimental settings, the research achieved its central objective of clarifying how human cells counteract herpesvirus infection. These findings contribute to a deeper understanding of virus-host interactions that influence disease progression and, in the longer term, may support the identification of new targets for antiviral therapies. This is particularly relevant in the current European and global context, where emerging and re-emerging viruses with neurological involvement are expanding into densely populated regions due to environmental change, demographic shifts, and increased human-animal contact.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Virus infections cause a major healthcare burden worldwide. The neurotropic human herpes simplex virus 1 (HSV-1) establishes life-long latent infection in neurons, from which it frequently reactivates to disseminate within the population. Clinical complications caused by HSV-1 infections range from mild (herpes labialis) to sight- (keratitis) and even life-threatening diseases (encephalitis). Prevention and treatment of HSV-1 infections are considered a top priority by the WHO. However, development of vaccines and improved therapeutic approaches is hindered by our incomplete understanding of the virus-host interactions that govern infection and disease, especially the interplay between HSV-1 and intrinsic neuronal defenses. The highly conserved cellular RNA degradation pathway nonsense-mediated decay (NMD), which regulates expression of ~10% of cellular transcripts and controls numerous fundamental processes, has recently emerged as an important regulator of neuronal function. Based on my previous postdoctoral studies that revealed a major role for NMD in controlling infection by oncogenic human herpesviruses combined with my preliminary data on HSV-1, I hypothesize that NMD provides an intrinsic defense mechanism that controls HSV-1 infection. In this fellowship, I propose to combine my experience and the expertise of the host institute to determine the physiological relevance and molecular mechanism by which NMD controls HSV-1 infection in its natural human host. Successful completion of my project will lead to improved insight into the virus-host interactions that control infection of HSV-1, thereby providing novel therapeutic targets to combat HSV-1 infection and pathogenesis. Moreover, the extensive and multidisciplinary training in research and transferrable skills provided by this fellowship will be invaluable for my goal of becoming an all-round competitive scientist leading an independent research group focused on intrinsic immunity to neurotropic viruses.
Оригинален текст от CORDIS (на английски).
Участници
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM · RotterdamКоординаторНидерландия
Връзки
- Виж в CORDIS
- DOI: 10.3030/101066372
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e528f984f8&appId=PPGMS
- https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5f76899a3&appId=PPGMS
Данни: CORDIS, © Европейски съюз
